92%Confidence
0Views
FDASource
2026-03-15Date
Summary
Wizcure Pharmaa's Vista Gel eye drops recalled for sterility concerns, another in a series of cGMP failures at their Bhiwadi facility. This pattern suggests significant quality management deficiencies that could jeopardize hi-health's product portfolio and brand reputation.
Actionable: Evaluate hi-health's dependency on Wizcure Pharmaa and develop contingency plans for sourcing ophthalmic lubricants from more reliable manufacturers.
AI Confidence: 92%
Data Points
firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productVista Gel Hypromellose USP 0.3% w/v, Eye Drops Dry Eye Relief Lubricating Gel, 10 ml. (1/3 fl. oz), Wizcure Pharmaa PVT. LTD, H-881, Phase-3, RIICO In
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now